Browsing Clinical Medicine (Scholarly Publications) by Author "BEDE, PETER"
Now showing items 1-6 of 6
- Sort by:
- title
- issue date
- submit date
- Order:
- ascending
- descending
- Results:
- 5
- 10
- 20
- 40
- 60
- 80
- 100
-
23. Lessons of ALS imaging: Pitfalls and future directions - A critical review.
HARDIMAN, ORLA; BEDE, PETER (2014)Stereotypical shortcomings can be identified in ALS neuroimaging studies. • A systematic discussion of ALS study limitations is particularly timely. • Individual patient data meta-analyses and multicentre ... -
Lessons of ALS imaging: Pitfalls and future directions - A critical review
BEDE, PETER; HARDIMAN, ORLA (2014)Background: While neuroimaging in ALS has gained unprecedented momentum in recent years, little progress has been made in the development of viable diagnostic, prognostic and monitoring markers. Objectives: To identify ... -
Patterns of cerebral and cerebellar white matter degeneration in ALS.
HARDIMAN, ORLA; BEDE, PETER; BRADLEY, DANIEL (2015) -
Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm
BEDE, PETER; HARDIMAN, ORLA; PENDER, NIALL (2015)The objective of the study was to develop and validate a practical prognostic index for patients with amyotrophic lateral scleroses (ALS) using information available at the first clinical consultation. We interrogated datasets ... -
Presymptomatic and longitudinal neuroimaging in neurodegeneration: from snapshots to motion picture - a systematic review
HARDIMAN, ORLA; BEDE, PETER (2015)Background Recent quantitative neuroimaging studies have been successful in capturing phenotype and genotype-speci fi c changes in dementia syndromes, amyotrophic lateral sclerosis, Parkinson ’ s disease and other ... -
Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics
BEDE, PETER; HARDIMAN, ORLA; Schuster, Claudia (2017)Background: Amyotrophic lateral sclerosis (ALS) a highly heterogeneous neurodegenerative condition. Accurate diagnostic, monitoring and prognostic biomarkers are urgently needed both for individualised patient care and ...